myStage Dx
CE | H&E
myStage Dx is a software-only in vitro diagnostic (IVD) device intended to assess the risk of distant metastasis within nine years from diagnosis in adult patients with stage II-III, node-positive, ER-positive, HER2-negative breast cancer.